Anabond Stedman Pharma Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.95 M
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.50 M
- Revenue Growth 46.41%
- Profit Growth 251.75%
- Ebitda 462.84%
- Net Worth 7.99%
- Total Assets 2.56%
About Anabond Stedman Pharma Research
Anabond Stedman Pharma Research Private Limited (ASPRPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2004 and has a history of 20 years and two months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.95 M.
The company has closed loans amounting to ₹4.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajagopal Rangachari, Ramkumar Rajagopal, and Abraham Sankarathil serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33112TN2004PTC054628
- Company No.
054628
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2004
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Anabond Stedman Pharma Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajagopal Rangachari  | Director | 09-Nov-2004 | Current |
| Ramkumar Rajagopal | Director | 09-Nov-2004 | Current |
| Abraham Sankarathil | Director | 16-Dec-2020 | Current |
Financial Performance of Anabond Stedman Pharma Research.
Anabond Stedman Pharma Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.41% increase. The company also saw a substantial improvement in profitability, with a 251.75% increase in profit. The company's net worth moved up by a moderate rise of 7.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anabond Stedman Pharma Research?
In 2018, Anabond Stedman Pharma Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stedman Pharmaceuticals Private LimitedRajagopal Rangachari and Ramkumar Rajagopal are mutual person
Anabond LtdAbraham Sankarathil is a mutual person
Talon Tack Private LimitedAbraham Sankarathil is a mutual person
Charges (Loans)
₹0
₹0.45 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Ltd. : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2005 | Hdfc Bank Ltd. | ₹4.50 M | Satisfied |
How Many Employees Work at Anabond Stedman Pharma Research?
Unlock and access historical data on people associated with Anabond Stedman Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anabond Stedman Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anabond Stedman Pharma Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
